Ingrid Kane
Direttore Tecnico/Scientifico/R&S presso SIGHT SCIENCES, INC.
Posizioni attive di Ingrid Kane
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SIGHT SCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | - | - |
Storia della carriera di Ingrid Kane
Precedenti posizioni note di Ingrid Kane
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
iScience Interventional Corp.
 iScience Interventional Corp. Medical/Nursing ServicesHealth Services iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA. | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di Ingrid Kane
| University of Charles | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Repubblica Ceca | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 2 |
| Health Services | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SIGHT SCIENCES, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
iScience Interventional Corp.
iScience Interventional Corp. Medical/Nursing ServicesHealth Services iScience Interventional Corp. discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. It encompasses microcatheter-based therapies designed to access anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye. The firm addresses the previously unmet need for treatment of sight-threatening diseases with the innovative, minimally invasive iCath™ procedures. The company was founded by Michael F. Nash and Stan Conston in 1999 and is headquartered in Menlo Park, CA. | Health Services |
- Borsa valori
- Insiders
- Ingrid Kane
- Esperienza
